Sign in
4

Changes in Ownership

Akebia Therapeutics, Inc. Filed Acc 0001209191-15-024946

CEO and President acquired 100,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Butler John P. · CEO and President

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2015-03-09 Exercise or conversion : show line 1 in the form +100,000 $0.47 $47,000 148,350 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2015-03-09 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) −100,000 0 D
Loading xslF345X03/doc4.xml…